Literature DB >> 30746186

Diagnostic value of acid phosphatases (ACP) in differentiating reactive mesothelial cells from cancer cells in the body fluid effusions.

Yun-Hui Li1, Yang Wang2, Xiu-Xia Chen3, Bin Liang4, Xue-Shan Qiu5, En-Hua Wang5, Guang-Ping Wu5.   

Abstract

BACKGROUND: The cytological diagnosis of a malignant epithelial tumor, i.e., a cancer cell in the body fluid effusions is usually made by cytomorphological examination alone; however, diagnostic challenges can occur when the cancer cells are rare or cytological atypia is minimal. Morphological similarity between the cancer and the reactive mesothelial cell is the most common problem in establishing a clear diagnosis. The aim of this study is to investigate whether the cocktail acid phosphatases (ACP) special staining will be a useful tumor marker in differentiation of the reactive mesothelial cells from the cancer cells in the body fluid effusions.
METHODS: The cocktail ACP special staining was performed on 212 body fluid effusion samples, which included 128 pleural effusions, 69 ascites, and 15 pericardial effusions.
RESULTS: The mesothelial cells were cocktail ACP positive in 84 out of 84 benign effusion cases, and the sensitivity and the specificity were 100% for the benign effusions which including pleural effusions, ascites, and pericardial effusions. On the other hand, 122 out of 128 cancer cases were cocktail ACP negative, indicating that the sensitivity of using the cocktail ACP staining to rule out the malignant effusions was 95.3%. Thus, the cocktail ACP staining is an excellent marker with high sensitivity and specificity to distinguish the carcinoma from the reactive mesothelial cells in the body fluid effusions.
CONCLUSIONS: Our finding provided a new tool for cytopathologists in diagnosing the body fluid effusion that could impact clinical decision making.

Entities:  

Keywords:  Cytopathology; acid phosphatases (ACP); effusion; mesothelial cells, carcinoma

Year:  2018        PMID: 30746186      PMCID: PMC6344779          DOI: 10.21037/jtd.2018.11.64

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  20 in total

Review 1.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

2.  Tartrate-resistant acid phosphatase as an immunohistochemical marker for inflammatory macrophages.

Authors:  Anthony J Janckila; Stephen P Slone; Sheron C Lear; Alvin Martin; Lung T Yam
Journal:  Am J Clin Pathol       Date:  2007-04       Impact factor: 2.493

3.  Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.

Authors:  G M Yousef; M Diamandis; K Jung; E P Diamandis
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

4.  Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.

Authors:  Alexander Kirschenbaum; Xin-Hua Liu; Shen Yao; Amanda Leiter; Alice C Levine
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

5.  Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.

Authors:  Ekaterini Politi; Christina Kandaraki; Caterina Apostolopoulou; Thomais Kyritsi; Helen Koutselini
Journal:  Diagn Cytopathol       Date:  2005-03       Impact factor: 1.582

6.  Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.

Authors:  Alaa M Afify; Robert Stern; Claire W Michael
Journal:  Diagn Cytopathol       Date:  2005-03       Impact factor: 1.582

7.  Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.

Authors:  G-P Wu; S-S Zhang; C-Q Fang; S-L Liu; E-H Wang
Journal:  Cytopathology       Date:  2008-08       Impact factor: 2.073

8.  Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.

Authors:  Takahiro Goto; Hirotaka Kawano; Toru Akiyama; Yusuke Shinoda; Tomotake Okuma; Hiroshi Kobayashi; Tetsuo Nemoto; Nobuaki Funata
Journal:  Arch Orthop Trauma Surg       Date:  2009-03-25       Impact factor: 3.067

Review 9.  Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.

Authors:  S K Mohanty; P Dey
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

View more
  1 in total

1.  Screening for malignant tumor cells in serous effusions with an automatic hematology analyzer using a novel diagnostic algorithm.

Authors:  Dehua Sun; Xinru Mao; Taixue An; Xiaojing He; Kai Qiu; Yuhong Luo; Zheyuan Qin; Yongjian He; Tie Xiong; Houmei Feng; Jin Li; Lei Zheng
Journal:  Ann Transl Med       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.